Q&A: Omalizumab provides protective effect for multiple food allergies

WASHINGTON — Patients with multiple food allergies experienced a protective effect against allergic reactions with omalizumab, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
In the OUtMATCH study, patients aged 1 to 55 years with allergies to peanut and two other foods confirmed by food challenges received omalizumab (Xolair, Genentech/Novartis; n = 120) or placebo (n = 60) for 16 weeks, followed by additional food challenges.
Two-thirds (66.7%) of the treatment group and 6.7% of the placebo group tolerated 600 mg or more of

WASHINGTON — Patients with multiple food allergies experienced a protective effect against allergic reactions with omalizumab, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
In the OUtMATCH study, patients aged 1 to 55 years with allergies to peanut and two other foods confirmed by food challenges received omalizumab (Xolair, Genentech/Novartis; n = 120) or placebo (n = 60) for 16 weeks, followed by additional food challenges.
Two-thirds (66.7%) of the treatment group and 6.7% of the placebo group tolerated 600 mg or more of